Dr Kevin Gorman was appointed the head of Oxitec Ltd’s Chief Development Officer in 2020. Kevin is responsible for operational success and performance of all field deployments, generating new opportunities for Oxitec’s technology and ensuring regulatory advances and compliance. Kevin has 30 years’ experience as an agricultural and public health entomologist, with a career focus on integrated and sustainable pest management practices. Previously a Project Lead for regulatory efficacy trials and a public-sector academic, he has extensive line management and project management experience. Kevin has authored over 70 publications and has also served on the editorial boards of two leading international journals. 

Kevin joined Oxitec in 2012 as the technical lead in Central America and the Indian sub-continent for insect control programs using Oxitec’s genetic technologies. Kevin led Oxitec trials in Panama and India with emphasis on the mosquito vectors responsible for transmission of dengue, chikungunya, and Zika viruses. He served as a bridge between technical and business sectors with significant contributions to funding streams and international regulatory processes. In 2021, following his role as Global Head of Field Operations and Delivery, Kevin took up his current role of Chief Development Officer with responsibility for expanding Oxitec’s product pipeline and opening new market opportunities.

Kevin lives in Buckinghamshire, England with his wife Gabriela and their two children.